James Sorensen, PhD

InstitutionUniversity of California San Francisco
Address1001 Potrero Ave
San Francisco CA 94110
vCardDownload vCard

    Collapse Overview 

    Collapse Research 
    Collapse Research Activities and Funding
    Mentoring Early-Career Scientists for Drug Abuse Research Careers
    NIH/NIDA R25DA035163May 1, 2014 - Apr 30, 2019
    Role: Co-Principal Investigator
    NIH/NIDA R21DA020369Sep 30, 2006 - May 31, 2010
    Role: Principal Investigator
    Western States Node of the National Drug Abuse Treatment Clinical Trials Network
    NIH/NIDA UG1DA015815Sep 30, 2002 - May 31, 2020
    Role: Principal Investigator
    Western States Node of the National Drug Abuse Treatment Clinical Trials Network
    NIH/NIDA U10DA015815Sep 30, 2002 - Aug 31, 2015
    Role: Principal Investigator
    Therapeutic Community and Opioid Replacement Therapy
    NIH/NIDA R01DA014922Sep 30, 2001 - May 31, 2008
    Role: Principal Investigator
    NIH/NIDA R01DA011344Sep 30, 1997 - Jul 31, 2001
    Role: Principal Investigator
    Treatment for Complex Patients: Continuing and Extended Care
    NIH/NIDA P50DA009253Sep 29, 1994 - May 31, 2015
    Role: Co-Investigator
    NIH/NIDA R01DA008753Sep 30, 1993 - Jun 30, 2000
    Role: Principal Investigator
    Drug Abuse Treatment/Services Research Training Program
    NIH/NIDA T32DA007250Sep 30, 1991 - Jun 30, 2019
    Role: Principal Investigator
    NIH/NIDA R18DA006097Sep 30, 1989 - Aug 31, 1996
    Role: Principal Investigator
    NIH/NIDA R01DA004340Sep 1, 1987 - Dec 31, 1990
    Role: Principal Investigator
    NIH/NIDA R01DA003363Sep 1, 1983 - Aug 31, 1988
    Role: Principal Investigator
    NIH/NIDA R01DA003057Apr 1, 1981 - Jun 30, 1987
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse In The News

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Chang JS, Sorensen J, Masson CL, Shopshire MS, Hoffman K, McCarty D, Iguchi M. Structural factors affecting Asians and Pacific Islanders in community-based substance use treatment: Treatment provider perspectives. J Ethn Subst Abuse. 2017 Oct-Dec; 16(4):479-494. PMID: 29236627.
      View in: PubMed
    2. Chang JS, Chiu JD, Gruber VA, Sorensen J. Fair hearing outcomes of patients recommended discharge from methadone maintenance. J Subst Abuse Treat. 2017 Dec; 83:68-72. PMID: 28919058.
      View in: PubMed
    3. Stitzer M, Matheson T, Cunningham C, Sorensen J, Feaster DJ, Gooden L, Hammond AS, Fitzsimons H, Metsch LR. Enhancing patient navigation to improve intervention session attendance and viral load suppression of persons with HIV and substance use: a secondary post hoc analysis of the Project HOPE study. Addict Sci Clin Pract. 2017 06 27; 12(1):16. PMID: 28651612.
      View in: PubMed
    4. Newville H, Sorensen J, Hatch-Maillette M, Calsyn DA. Temporal Relationship of Sex Risk Behaviors and Substance Use Severity Among Men in Substance Use Treatment. J Sex Res. 2017 May 17; 1-9. PMID: 28513227.
      View in: PubMed
    5. McKnight C, Shumway M, Masson CL, Pouget ER, Jordan AE, Des Jarlais DC, Sorensen J, Perlman DC. Perceived discrimination among racial and ethnic minority drug users and the association with health care utilization. J Ethn Subst Abuse. 2017 Oct-Dec; 16(4):404-419. PMID: 28306386.
      View in: PubMed
    6. Korthuis PT, Lum PJ, Vergara-Rodriguez P, Ahamad K, Wood E, Kunkel LE, Oden NL, Lindblad R, Sorensen J, Arenas V, Ha D, Mandler RN, McCarty D. Feasibility and safety of extended-release naltrexone treatment of opioid and alcohol use disorder in HIV clinics: a pilot/feasibility randomized trial. Addiction. 2017 Jun; 112(6):1036-1044. PMID: 28061017.
      View in: PubMed
    7. Grelotti DJ, Hammer GP, Dilley JW, Karasic DH, Sorensen J, Bangsberg DR, Tsai AC. Does substance use compromise depression treatment in persons with HIV? Findings from a randomized controlled trial. AIDS Care. 2017 Mar; 29(3):273-279. PMID: 27590273.
      View in: PubMed
    8. Stitzer M, Calsyn D, Matheson T, Sorensen J, Gooden L, Metsch L. Development of a Multi-Target Contingency Management Intervention for HIV Positive Substance Users. J Subst Abuse Treat. 2017 01; 72:66-71. PMID: 27624618.
      View in: PubMed
    9. Metsch LR, Feaster DJ, Gooden L, Matheson T, Stitzer M, Das M, Jain MK, Rodriguez AE, Armstrong WS, Lucas GM, Nijhawan AE, Drainoni ML, Herrera P, Vergara-Rodriguez P, Jacobson JM, Mugavero MJ, Sullivan M, Daar ES, McMahon DK, Ferris DC, Lindblad R, VanVeldhuisen P, Oden N, Castellón PC, Tross S, Haynes LF, Douaihy A, Sorensen J, Metzger DS, Mandler RN, Colfax GN, del Rio C. Effect of Patient Navigation With or Without Financial Incentives on Viral Suppression Among Hospitalized Patients With HIV Infection and Substance Use: A Randomized Clinical Trial. JAMA. 2016 Jul 12; 316(2):156-70. PMID: 27404184.
      View in: PubMed
    10. Flentje A, Livingston NA, Sorensen J. Meeting the Needs of Lesbian, Gay, and Bisexual Clients in Substance Abuse Treatment. Counselor (Deerfield Beach). 2016 May-Jun; 17(3):54-59. PMID: 28111527.
      View in: PubMed
    11. Flentje A, Livingston NA, Roley J, Sorensen J. Mental and Physical Health Needs of Lesbian, Gay, and Bisexual Clients in Substance Abuse Treatment. J Subst Abuse Treat. 2015 Nov; 58:78-83. PMID: 26314505; PMCID: PMC4581963 [Available on 11/01/16].
    12. Guydish J, Masson C, Flentje A, Shopshire M, Sorensen J. Scientific writing seminar for early-stage investigators in substance abuse research. Subst Abus. 2016; 37(1):238-41. PMID: 25893689; PMCID: PMC4615274 [Available on 01/01/17].
    13. Flentje A, Heck NC, Sorensen J. Substance use among lesbian, gay, and bisexual clients entering substance abuse treatment: Comparisons to heterosexual clients. J Consult Clin Psychol. 2015 Apr; 83(2):325-34. PMID: 25622196; PMCID: PMC4380585.
    14. Woody G, Bruce D, Korthuis PT, Chhatre S, Hillhouse M, Jacobs P, Sorensen J, Saxon AJ, Poole S, Metzger D, Ling W. Authors' reply: "Risk reduction with buprenorphine-naloxone and methadone: patient's choice". J Acquir Immune Defic Syndr. 2014 Dec 15; 67(5):e142-3. PMID: 25243431; PMCID: PMC4229390.
    15. Newville H, Roley J, Sorensen J. Prescription medication misuse among HIV-infected individuals taking antiretroviral therapy. J Subst Abuse Treat. 2015 Jan; 48(1):56-61. PMID: 25245428; PMCID: PMC4250322.
    16. Woody GE, Bruce D, Korthuis PT, Chhatre S, Poole S, Hillhouse M, Jacobs P, Sorensen J, Saxon AJ, Metzger D, Ling W. HIV risk reduction with buprenorphine-naloxone or methadone: findings from a randomized trial. J Acquir Immune Defic Syndr. 2014 Jul 01; 66(3):288-93. PMID: 24751432; PMCID: PMC4146664.
    17. Flentje A, Heck NC, Sorensen J. Characteristics of transgender individuals entering substance abuse treatment. Addict Behav. 2014 May; 39(5):969-75. PMID: 24561017; PMCID: PMC4130569.
    18. Perlman DC, Jordan AE, McKnight C, Young C, Delucchi KL, Sorensen J, Des Jarlais DC, Masson CL. Viral hepatitis among drug users in methadone maintenance: associated factors, vaccination outcomes, and interventions. J Addict Dis. 2014; 33(4):322-31. PMID: 25299236; PMCID: PMC4275379.
    19. Larios SE, Masson CL, Shopshire MS, Hettema J, Jordan AE, McKnight C, Young C, Khalili M, Seewald RM, Min A, Hengl N, Sorensen J, Des Jarlais DC, Perlman DC. Education and counseling in the methadone treatment setting improves knowledge of viral hepatitis. J Subst Abuse Treat. 2014 Apr; 46(4):528-31. PMID: 24462241; PMCID: PMC4019752.
    20. Tsai AC, Mimiaga MJ, Dilley JW, Hammer GP, Karasic DH, Charlebois ED, Sorensen J, Safren SA, Bangsberg DR. Does effective depression treatment alone reduce secondary HIV transmission risk? Equivocal findings from a randomized controlled trial. AIDS Behav. 2013 Oct; 17(8):2765-72. PMID: 23975476; PMCID: PMC3805275.
    21. Manuel JK, Newville H, Larios SE, Sorensen J. Confidentiality protections versus collaborative care in the treatment of substance use disorders. Addict Sci Clin Pract. 2013 Aug 26; 8:13. PMID: 23972141; PMCID: PMC3766245.
    22. Masson CL, Delucchi KL, McKnight C, Hettema J, Khalili M, Min A, Jordan AE, Pepper N, Hall J, Hengl NS, Young C, Shopshire MS, Manuel JK, Coffin L, Hammer H, Shapiro B, Seewald RM, Bodenheimer HC, Sorensen J, Des Jarlais DC, Perlman DC. A randomized trial of a hepatitis care coordination model in methadone maintenance treatment. Am J Public Health. 2013 Oct; 103(10):e81-8. PMID: 23947319; PMCID: PMC3853128.
    23. Jordan AE, Masson CL, Mateu-Gelabert P, McKnight C, Pepper N, Bouche K, Guzman L, Kletter E, Seewald RM, Des-Jarlais DC, Sorensen J, Perlman DC. Perceptions of drug users regarding hepatitis C screening and care: a qualitative study. Harm Reduct J. 2013 Jun 20; 10:10. PMID: 23786800; PMCID: PMC3695813.
    24. Newville H, Sorensen J. The efficacy of a computerized assessment of medication adherence in active substance users. J Int Assoc Provid AIDS Care. 2013 Jul-Aug; 12(4):232-5. PMID: 23719238; PMCID: PMC4133995.
    25. Flentje A, Sorensen J. Empirically supported drug treatment for all: Helping a nation get "Clean" Psyccritiques. 2013; 58(45). PMID: 24976802.
      View in: PubMed
    26. Manuel JK, Lum PJ, Hengl NS, Sorensen J. Smoking cessation interventions with female smokers living with HIV/AIDS: a randomized pilot study of motivational interviewing. AIDS Care. 2013; 25(7):820-7. PMID: 23116051; PMCID: PMC3625696.
    27. Sorensen J, Haug NA, Larios S, Gruber VA, Tulsky J, Powelson E, Logan DP, Shapiro B. Directly administered antiretroviral therapy: pilot study of a structural intervention in methadone maintenance. J Subst Abuse Treat. 2012 Dec; 43(4):418-23. PMID: 23007110; PMCID: PMC3484182.
    28. Masson CL, Shopshire MS, Sen S, Hoffman KA, Hengl NS, Bartolome J, McCarty D, Sorensen J, Iguchi MY. Possible barriers to enrollment in substance abuse treatment among a diverse sample of Asian Americans and Pacific Islanders: opinions of treatment clients. J Subst Abuse Treat. 2013 Mar; 44(3):309-15. PMID: 22985677; PMCID: PMC3545039.
    29. Tsai AC, Karasic DH, Hammer GP, Charlebois ED, Ragland K, Moss AR, Sorensen J, Dilley JW, Bangsberg DR. Directly observed antidepressant medication treatment and HIV outcomes among homeless and marginally housed HIV-positive adults: a randomized controlled trial. Am J Public Health. 2013 Feb; 103(2):308-15. PMID: 22720766; PMCID: PMC3558777.
    30. Metsch LR, Feaster DJ, Gooden L, Matheson T, Mandler RN, Haynes L, Tross S, Kyle T, Gallup D, Kosinski AS, Douaihy A, Schackman BR, Das M, Lindblad R, Erickson S, Korthuis PT, Martino S, Sorensen J, Szapocznik J, Walensky R, Branson B, Colfax GN. Implementing rapid HIV testing with or without risk-reduction counseling in drug treatment centers: results of a randomized trial. Am J Public Health. 2012 Jun; 102(6):1160-7. PMID: 22515871; PMCID: PMC3483949.
    31. Korthuis PT, Feaster DJ, Gomez ZL, Das M, Tross S, Wiest K, Douaihy A, Mandler RN, Sorensen J, Colfax G, McCarty D, Cohen SE, Penn PE, Lape D, Metsch LR. Injection behaviors among injection drug users in treatment: the role of hepatitis C awareness. Addict Behav. 2012 Apr; 37(4):552-5. PMID: 22209655; PMCID: PMC3288438.
    32. Larios SE, Wright S, Jernstrom A, Lebron D, Sorensen J. Evidence-based practices, attitudes, and beliefs in substance abuse treatment programs serving American Indians and Alaska Natives: a qualitative study. J Psychoactive Drugs. 2011 Oct-Dec; 43(4):355-9. PMID: 22400469; PMCID: PMC4760647.
    33. Tross S, Campbell AN, Calsyn DA, Metsch LR, Sorensen J, Shoptaw S, Haynes L, Woody GE, Malow RM, Brown LS, Feaster DJ, Booth RE, Mandler RN, Masson C, Holmes BW, Colfax G, Brooks AJ, Hien DA, Schackman BR, Korthuis PT, Miele GM. NIDA's Clinical Trials Network: an opportunity for HIV research in community substance abuse treatment programs. Am J Drug Alcohol Abuse. 2011 Sep; 37(5):283-93. PMID: 21854270; PMCID: PMC3361073.
    34. Riley ED, Moore K, Sorensen J, Tulsky JP, Bangsberg DR, Neilands TB. Basic subsistence needs and overall health among human immunodeficiency virus-infected homeless and unstably housed women. Am J Epidemiol. 2011 Sep 01; 174(5):515-22. PMID: 21749972; PMCID: PMC3161197.
    35. Sorensen J, Kosten T. Developing the tools of implementation science in substance use disorders treatment: applications of the consolidated framework for implementation research. Psychol Addict Behav. 2011 Jun; 25(2):262-8. PMID: 21668086; PMCID: PMC3126630.
    36. Sorensen J. From Cat's Cradle to Beat the Reaper: getting evidence-based treatments into practice in spite of ourselves. Addict Behav. 2011 Jun; 36(6):597-600. PMID: 21330063; PMCID: PMC3085322.
    37. Masson CL, Sorensen J, Grossman N, Sporer KA, Des Jarlais DC, Perlman DC. Organizational issues in the implementation of a hospital-based syringe exchange program. Subst Use Misuse. 2010 May; 45(6):901-15. PMID: 20397875; PMCID: PMC3378397.
    38. Song YS, Calsyn DA, Doyle SR, Dierst-Davies R, Chen T, Sorensen J. Predictors of condom use among men enrolled in drug treatment programs. AIDS Educ Prev. 2009 Oct; 21(5):460-73. PMID: 19842829; PMCID: PMC3689147.
    39. Chun J, Haug NA, Guydish JR, Sorensen J, Delucchi K. Cigarette smoking among opioid-dependent clients in a therapeutic community. Am J Addict. 2009 Jul-Aug; 18(4):316-20. PMID: 19444736; PMCID: PMC2756535.
    40. Hettema JE, Sorensen J, Uy M, Jain S. Motivational enhancement therapy to increase resident physician engagement in substance abuse education. Subst Abus. 2009 Jul-Sep; 30(3):244-7. PMID: 19591061; PMCID: PMC2743880.
    41. Hettema JE, Sorensen J. Access to Care for Methadone Maintenance Patients in the United States. Int J Ment Health Addict. 2009 Jul; 7(3):468-474. PMID: 22876215.
      View in: PubMed
    42. McCarty D, Roman PM, Sorensen J, Weisner C. Health Services Research for Drug and Alcohol Treatment and Prevention. J Drug Issues. 2009 Jan; 39(1):197-208. PMID: 23378669.
      View in: PubMed
    43. Chen T, Masson CL, Sorensen J, Greenberg B. Residential treatment modifications: adjunctive services to accommodate clients on methadone. Am J Drug Alcohol Abuse. 2009; 35(2):91-4. PMID: 19259872; PMCID: PMC3558978.
    44. Barnett PG, Sorensen J, Wong W, Haug NA, Hall SM. Effect of incentives for medication adherence on health care use and costs in methadone patients with HIV. Drug Alcohol Depend. 2009 Feb 01; 100(1-2):115-21. PMID: 19054631; PMCID: PMC2715338.
    45. Sorensen J, Andrews S, Delucchi KL, Greenberg B, Guydish J, Masson CL, Shopshire M. Methadone patients in the therapeutic community: a test of equivalency. Drug Alcohol Depend. 2009 Feb 01; 100(1-2):100-6. PMID: 19013724; PMCID: PMC2606930.
    46. Andrews S, Sorensen J, Guydish J, Delucchi K, Greenberg B. Knowledge and Attitudes About Methadone Maintenance Among Staff Working in a Therapeutic Community. J Maint Addict. 2005; 3(1):47-59. PMID: 23525520.
      View in: PubMed
    47. Haas AL, Sorensen J, Hall SM, Lin C, Delucchi K, Sporer K, Chen T. Cigarette smoking in opioid-using patients presenting for hospital-based medical services. Am J Addict. 2008 Jan-Feb; 17(1):65-9. PMID: 18214725.
      View in: PubMed
    48. Greenberg B, Hall DH, Sorensen J. Methadone maintenance therapy in residential therapeutic community settings: challenges and promise. J Psychoactive Drugs. 2007 Sep; 39(3):203-10. PMID: 18159773.
      View in: PubMed
    49. Sorensen J, Brown L, Calsyn D, Tross S, Booth RE, Song Y, Normand J. AIDS research in the NIDA Clinical Trials Network: emerging results. Drug Alcohol Depend. 2007 Jul 10; 89(2-3):310-3. PMID: 17590899.
      View in: PubMed
    50. Chun J, Guydish JR, Sorensen J, Haug NA, Andrews S, Nelson L. Outcomes in a Sample of Opiod-Dependent Clients Treated Under California's Proposition 36. J Drug Issues. 2007 Jul 01; 37(3):699-715. PMID: 22581981.
      View in: PubMed
    51. Riley ED, Weiser SD, Sorensen J, Dilworth S, Cohen J, Neilands TB. Housing patterns and correlates of homelessness differ by gender among individuals using San Francisco free food programs. J Urban Health. 2007 May; 84(3):415-22. PMID: 17265132; PMCID: PMC2231829.
    52. Masson CL, Sorensen J, Perlman DC, Shopshire MS, Delucchi KL, Chen T, Sporer K, Des Jarlais D, Hall SM. Hospital- versus community-based syringe exchange: a randomized controlled trial. AIDS Educ Prev. 2007 Apr; 19(2):97-110. PMID: 17411413; PMCID: PMC3853200.
    53. Sorensen J, Guydish J, Zilavy P, Davis TB, Gleghorn A, Jacoby M, Sears C. Access to drug abuse treatment under Treatment on Demand policy in San Francisco. Am J Drug Alcohol Abuse. 2007; 33(2):227-36. PMID: 17497545; PMCID: PMC3493250.
    54. Barnett PG, Masson CL, Sorensen J, Wong W, Hall S. Linking opioid-dependent hospital patients to drug treatment: Health care use and costs 6 months after randomization. Addiction. 2006 Dec; 101(12):1797-804. PMID: 17156179.
      View in: PubMed
    55. Haug NA, Sorensen J, Gruber VA, Lollo N, Roth G. HAART adherence strategies for methadone clients who are HIV-positive: a treatment manual for implementing contingency management and medication coaching. Behav Modif. 2006 Nov; 30(6):752-81. PMID: 17050764.
      View in: PubMed
    56. Haug NA, Sorensen J. Contingency management interventions for HIV-related behaviors. Curr HIV/AIDS Rep. 2006 Nov; 3(4):154-9. PMID: 17032574.
      View in: PubMed
    57. Sorensen J, Haug NA, Delucchi KL, Gruber V, Kletter E, Batki SL, Tulsky JP, Barnett P, Hall S. Voucher reinforcement improves medication adherence in HIV-positive methadone patients: a randomized trial. Drug Alcohol Depend. 2007 Apr 17; 88(1):54-63. PMID: 17056206; PMCID: PMC1976289.
    58. Wasserman DA, Sorensen J, Delucchi KL, Masson CL, Hall SM. Psychometric evaluation of the Quality of Life Interview, Brief Version, in injection drug users. Psychol Addict Behav. 2006 Sep; 20(3):316-21. PMID: 16938069.
      View in: PubMed
    59. Miller WR, Sorensen J, Selzer JA, Brigham GS. Disseminating evidence-based practices in substance abuse treatment: a review with suggestions. J Subst Abuse Treat. 2006 Jul; 31(1):25-39. PMID: 16814008.
      View in: PubMed
    60. Sorensen J. Abstinence incentives improve stimulant abusers' compliance with community-based psychosocial treatments. Evid Based Ment Health. 2006 May; 9(2):55. PMID: 16638904.
      View in: PubMed
    61. Sorensen J, Masson CL, Delucchi K, Sporer K, Barnett PG, Mitsuishi F, Lin C, Song Y, Chen T, Hall SM. Randomized trial of drug abuse treatment-linkage strategies. J Consult Clin Psychol. 2005 Dec; 73(6):1026-35. PMID: 16392976.
      View in: PubMed
    62. Prochaska JJ, Sorensen J, Hall SM, Rossi JS, Redding CA, Rosen AB, Eisendrath SJ, Meisner MR. Predictors of health functioning in two high-risk groups of smokers. Drug Alcohol Depend. 2005 May 09; 78(2):169-75. PMID: 15845320.
      View in: PubMed
    63. Sorensen J, Dilley J, London J, Okin RL, Delucchi KL, Phibbs CS. Case management for substance abusers with HIV/AIDS: a randomized clinical trial. Am J Drug Alcohol Abuse. 2003; 29(1):133-50. PMID: 12731685.
      View in: PubMed
    64. Sorensen J, Masson CL, Perlman DC. HIV/hepatitis prevention in drug abuse treatment programs: guidance from research. Sci Pract Perspect. 2002 Jul; 1(1):4-11. PMID: 18567957; PMCID: PMC2851052.
    65. Masson CL, Sorensen J, Batki SL, Okin R, Delucchi KL, Perlman DC. Medical service use and financial charges among opioid users at a public hospital. Drug Alcohol Depend. 2002 Mar 01; 66(1):45-50. PMID: 11850135.
      View in: PubMed
    66. Margolin A, Kleber HD, Avants SK, Konefal J, Gawin F, Stark E, Sorensen J, Midkiff E, Wells E, Jackson TR, Bullock M, Culliton PD, Boles S, Vaughan R. Acupuncture for the treatment of cocaine addiction: a randomized controlled trial. JAMA. 2002 Jan 02; 287(1):55-63. PMID: 11754709.
      View in: PubMed
    67. Sieber JE, Sorensen J. Conducting social and behavioral AIDS research in drug treatment clinics. IRB. 1992 Sep-Oct; 14(5):1-5. PMID: 11659481.
      View in: PubMed